Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among ...

To read all of these articles and more, visit centerforbiosimilars.com.